NORWALK, Conn.-- Walter M. Capone, COO of Norwalk's Multiple Myeloma Research Foundation, has been named to the 2013 PharmaVOICE 100.
The annual award recognizes top industry leaders for their positive contributions across sectors such as pharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, advocacy and more.
According to PharmaVOICE editors, "Collaboration and inventiveness define Walter Capone. These are the characteristics that have helped him in contributing to changing the treatment landscape for multiple myeloma patients.”
The 2013 PharmaVOICE 100 honorees were selected by editors based on thousands of nominations, and judged on their ability to motivate and influence research and development, technology, creativity and strategy.
"I am honored to be named to the PharmaVOICE 100 and to be recognized by my peers is such a humbling experience unto itself,” Capone said in a statement. “I have been incredibly fortunate to work closely with such extremely talented and passionate researchers, scientists and other partners who are accelerating the development of the next generation of myeloma treatments."
The complete list of honorees can be found by visiting PharmaVOICE online.